Once Weekly
FOSAMAX® is indicated for the treatment of osteoporosis in postmenopausal women
In postmenopausal women, FOSAMAX increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures)
Manufacturer # 78206013501
Brand FOSAMAX®
Manufacturer Organon USA Inc.
Country of Origin Unknown
Application Bone Resorption Inhibitor
Container Type Blister Pack
Dosage Form Tablet
Generic Drug Code 85361
Generic Drug Name Alendronate Sodium
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
NDC Number 78206013501
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Quantity 4 Tablets
Strength 70 mg
Supplier_ID 73544101
UNSPSC Code 51182406
